Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether Glyceryl Trinitrate (GTN) reduces injury to the heart during heart-lung bypass surgery in combination with the newer technique of remote ischaemic preconditioning (RIPC).


Clinical Trial Description

Ischaemic heart disease is a leading cause of mortality in the western world. A number of patients undergo coronary artery bypass graft (CABG) surgery as treatment for ischaemic heart disease. With the rise of interventional procedures, patients who are coming to have CABG surgery are higher risk1. Remote ischaemic preconditioning (RIPC) has been shown to reduce perioperative myocardial injury (PMI) in patients having CABG even when cold blood cardioplegia or intermittent cross clamp fibrillation is used as cardioprotective measures. These patients have a general anaesthetic with multiple infusions including Glyceryl Trinitrate (GTN). The use of GTN in these patients is based on theoretical assumptions of coronary vasodilation pre operatively along with maintaining graft potency postoperatively. We intend to investigate the effect of GTN in patients undergoing cardiac surgery being subjected to RIPC in its role as a Nitric Oxide (NO) donor. Exogenous NO has been shown to be cardioprotective in animal models. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01864252
Study type Interventional
Source University College, London
Contact
Status Completed
Phase Phase 3
Start date January 2014
Completion date February 2019

See also
  Status Clinical Trial Phase
Recruiting NCT00989508 - Myocardial Protection With Perhexiline in Left Ventricular Hypertrophy Phase 2/Phase 3
Not yet recruiting NCT04570514 - Optimized Cardioprotection Therapy in Obese Subjects With AMI
Active, not recruiting NCT01857414 - Effect of RIC on Clinical Outcomes in STEMI Patients Undergoing pPCI N/A
Completed NCT02342522 - Effect of Remote Ischaemic Conditioning on Clinical Outcomes in STEMI Patients Undergoing PPCI (CONDI2/ERIC-PPCI) N/A
Active, not recruiting NCT05462730 - Pulse Glucocorticoid Therapy in Patients With ST-Segment Elevation Myocardial Infarction Phase 2
Completed NCT04397939 - Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19
Withdrawn NCT02098629 - Concomitant Milrinone and Esmolol Treatment in Patients With Acute Myocardial Infarction Phase 1/Phase 2
Completed NCT00586820 - Role of Endothelin in Microvascular Dysfunction Following PCI for NSTEMI Phase 2
Completed NCT02390674 - Ciclosporin to Reduce Reperfusion Injury in Primary PCI Phase 2
Completed NCT00865722 - Remote Postconditioning in Patients With Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention (PCI) Phase 2/Phase 3
Recruiting NCT01307371 - Cell Therapy in Diabetic Patients With ST-Segment Elevation Myocardial Infarction(STEMI) Phase 1
Completed NCT01379261 - Efficacy of Endovascular Catheter Cooling Combined With Cold Saline for the Treatment of Acute Myocardial Infarction Phase 2/Phase 3
Completed NCT00881686 - Myocardial Protection With Adenosine Preconditioning Phase 1/Phase 2
Completed NCT00484575 - Inhaled Sevoflurane Compared to Intravenous Sedation Post Coronary Artery Bypass Grafting Phase 1/Phase 2
Recruiting NCT03995732 - Efficacy and Safety Evaluation of PC-SOD for Injection in Reducing Myocardial Reperfusion Injury Phase 2
Recruiting NCT05775380 - The Role of Pioglitazone in Vascular Transcriptional Remodeling Phase 4
Completed NCT06450912 - Wall Strain Index Ratio as a Biomarker for Mechanical Complication of Hemorrhagic Myocardial Infarction
Completed NCT05354648 - Effects of Hypoxic-hyperoxic Preconditioning in Cardio-surgical Patients N/A
Completed NCT01601795 - Sevoflurane and Isoflurane - During Cardiopulmonary Bypass With the MECC System (Minimized Extracorporeal Circuit) Phase 4
Completed NCT01354808 - ACCEL-LOADING-ACS Study Phase 4